- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 15/57 - Hydrolases (3) acting on peptide bonds (3.4)
Patent holdings for IPC class C12N 15/57
Total number of patents in this class: 401
10-year publication summary
21
|
16
|
16
|
26
|
19
|
30
|
31
|
18
|
23
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Danisco US Inc. | 1083 |
10 |
Novozymes A/S | 3301 |
8 |
Immatics Biotechnologies GmbH | 1168 |
7 |
Kao Corporation | 4898 |
6 |
Vertex Pharmaceuticals Incorporated | 1570 |
6 |
Concordia University | 100 |
5 |
The Procter & Gamble Company | 22148 |
4 |
Sanofi-Aventis Deutschland GmbH | 2604 |
4 |
President and Fellows of Harvard College | 5904 |
4 |
The Trustees of the University of Pennsylvania | 4251 |
4 |
Northwestern University | 3271 |
4 |
Amano Enzyme Inc. | 362 |
4 |
The Children's Hospital of Philadelphia | 748 |
4 |
Ipsen Biopharm Limited | 269 |
4 |
Jiangnan University | 1472 |
4 |
The University of British Columbia | 1464 |
4 |
The University of Queensland | 656 |
4 |
Chr. Hansen A/S | 991 |
4 |
The Regents of the University of California | 19479 |
3 |
Henkel AG & Co. KGaA | 10337 |
3 |
Other owners | 305 |